Overall survival (OS) of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC): final results of a phase Ill study (PARAMOUNT)

被引：0
|
作者：
Laack, E. [1 ]
Reck, M. [2 ]
Schumann, C. [3 ]
Eschbach, C. [4 ]
Kimmich, M. [5 ]
Brandts, C. [6 ]
Paz-Ares, L. G. [7 ]
De Marinis, F. [8 ]
Dediu, M. [9 ]
Pujol, J.-L. [10 ]
Bidoli, P. [11 ]
Molinier, O. [12 ]
Sahoo, T. P. [13 ]
Corral, J. [14 ]
Melemed, S. A. [14 ]
John, W. J. [14 ]
Chouaki, N. [15 ]
Zimmermann, A. H. [14 ]
Visseren-Grul, C. M. [16 ]
Leschinger, M., I [17 ]
Thomas, M. [18 ]
机构：
[1] Ambulantes Krebszentrum, Hamburg, Germany
[2] Krankenhaus Grosshansdorf, Grosshansdorf, Germany
[3] Univ Ulm Klinikum, Sekt Pneumol, Ulm, Germany
[4] Asklepios Klin Hamburg, Hamburg, Germany
[5] Klin Schillerhohe, Gerlingen, Germany
[6] Uniklin, Frankfurt, Germany
[7] Hosp Univ Virgen del Rocio, Seville, Spain
[8] San Camillo Forlanini Hosp, Rome, Italy
[9] Inst Oncol Bucharest, Bucharest, Romania
[10] Montpellier Univ Hosp, Montpellier, France
[11] Az Osped S Gerardo, Monza, Italy
[12] Les Mans Reg Hosp, Le Mans, France
[13] Jawaharlal Nehru Canc Hosp & Res Ctr, Bhopal, India
[14] Eli Lilly & Co, Indianapolis, IN 46285 USA
[15] Lilly France, Suresnes, France
[16] Lilly Oncol Europe, Houten, Netherlands
[17] Lilly Deutschland GmbH, Med, Oncol, Bad Homburg, Germany
[18] Univ Heidelberg, Thoraxklin, Heidelberg, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [41] Safety Data Analyses for First-Line Pemetrexed Plus Carboplatin (Pem plus Cb) in Nonsquamous Non-Small Cell Lung Cancer (ns-NSCLC)
    Okamoto, I.
    Schuette, W.
    Stinchcombe, T.
    Rodrigues Pereira, J.
    Liu, J.
    San Antonio, B.
    John, W.
    Chen, J.
    Zinner, R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S22 - S23
  • [42] Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer
    Schmid-Bindert, Gerald
    Gebbia, Vittorio
    Mayer, Frank
    Arriola, Edurne
    Marquez-Medina, Diego
    Syrigos, Kostas
    Biesma, Bonne
    Leschinger, Monika Iris
    Frimodt-Moller, Bente
    Ripoche, Veronique
    Myrand, Scott P.
    Nguyen, Tuan S.
    Hozak, Rebecca R.
    Zimmermann, Annamaria
    Visseren-Grul, Carla
    Schuette, Wolfgang
    [J]. LUNG CANCER, 2013, 81 (03) : 428 - 434
  • [43] Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).
    Zhang, Y
    Zhang, L
    Li, N
    Xu, F
    Pan, ZK
    Guang, ZZ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [44] PALLIATIVE RADIATION DURING PEMETREXED PLUS CISPLATIN FIRST-LINE TREATMENT OR PEMETREXED CONTINUATION MAINTENANCE TREATMENT IN ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A REPORT OF PATIENT SAFETY IN THE PARAMOUNT TRIAL
    De Marinis, Filippo
    Gridelli, Cesare
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Lois
    Molinier, Olivier
    Reck, Martin
    Sahoo, Tarini P.
    San Antonio, Belen
    John, William J.
    Zimmermann, Annamaria H.
    Chouaki, Nadia
    Visseren-Grul, Carla
    Paz-Arez, Luis G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S842 - S843
  • [45] A Dose-Finding and Phase 2 Study of Ruxolitinib plus Pemetrexed/Cisplatin for Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
    Giaccone, Giuseppe
    Sanborn, Rachel
    Waqar, Saiama
    Martinez, Alex
    Ponce, Santiago
    Zhen, Huiling
    Kennealey, Gerard
    Erickson-Viitanen, Susan
    Schaefer, Eric
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S895 - S896
  • [46] Taxotere® (TXT) versus best supportive care (BSC) in chemonaive patients with unresectable non-small cell lung cancer (NSCLC):: Final results of the phase iii study
    Roszkowski, K
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S246 - S246
  • [47] Effect of maintenance bevacizumab (Bev) plus pemetrexed (Pem) after first-line cisplatin/Pem/Bev in advanced nonsquamous non-small cell lung cancer (nsNSCLC) on overall survival (OS) of patients (pts) on the AVAPERL (MO22089) phase III randomized trial.
    Rittmeyer, Achim
    Scherpereel, Arnaud
    Gorbunova, Vera A.
    Gervais, Radj
    Vikstrom, Anders
    Chouaid, Christos
    Chella, Antonio
    Kim, Joo-Hang
    Ahn, Myung-Ju
    Reck, Martin
    Pazzola, Antonio
    Kim, Heung Tae
    Aerts, Joachim
    Groen, Harry J. M.
    Morando, Claire
    Loundou, Anderson
    Barlesi, Fabrice
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] Comparison of pemetrexed plus cisplatin versus pemetrexed plus carboplatin in the initial treatment of locally advanced or metastatic non-small cell lung cancer
    Pereira, A. A. R.
    Lessa, R. C.
    Souza, C. E. P.
    Pinto, F. A. I.
    Gagliato, D. M.
    Santos, E. S.
    Fanelli, M. F.
    Rinck, J. A.
    Dettino, A. A.
    Nicolau, U. R.
    Chinen, L. T. D.
    de Lima, V. C. C.
    Pereira, J. R.
    Cruz, M. R. D. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] GILT study: Oral vinorelbine (NVBo) and cisplatin (P) with concomitant radiotherapy (RT) followed by either consolidation (C) with NVBo plus P plus best supportive care (BSC) or BSC alone in stage (st) III non-small cell lung cancer (NSCLC): Final results of a phase (ph) III study
    Huber, Rudolf M.
    Engel-Riedel, Walburga
    Kollmeier, Jens
    Andreas, Stefan
    Staar, Susanne
    Klautke, Gunther
    Fietkau, Rainer
    Vaissiere, Nathalie
    Osowski, Susanne
    Flentje, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Pharmacogenetic study of Japanese patients with advanced nonsquamous non-small cell lung cancer treated with pemetrexed plus cisplatin
    Imai, Hisao
    Serizawa, Masakuni
    Takahashi, Toshiaki
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345